Introduction {#sec1}
============

In mammalian cells, DNA is packaged into chromatin, which can be differentially modified in association with different transcriptional states. Modifications associated with transcribed euchromatin include histone acetylation, H3K4me3 at promoters, and H3K36me3 within the gene body. The reversible gene silencing at facultative heterochromatin is mediated by H3K27me3 and the Polycomb group proteins, while permanent silencing of repetitive constitutive heterochromatin is linked to DNA methylation, H3K9me3, and H4K20me3. These epigenetic modifications are thought to contribute to gene regulation and to provide a template for cellular identity, heritable through cell divisions.

As modified histones are displaced from DNA during replication, the maintenance of chromatin states is dependent on the rapid reassembly of chromatin onto newly replicated DNA ([@bib22]). The reassembled chromatin is composed of a mixture of recycled, modified histones and naive histones ([@bib17; @bib21]) newly synthesized during the S phase. The preservation of chromatin modifications in daughter cells theoretically could be accomplished by chromatin modifiers recognizing specific marks on recycled histones and imparting these same marks on adjacent newly synthesized histones ([@bib1; @bib17]).

Histone displacement is not only linked to DNA replication but also can occur spontaneously or during processes such as transcription ([@bib2; @bib35; @bib38]) and DNA repair (reviewed in [@bib41]). However, as synthesis of canonical histones is restricted to the S phase, replication-independent histone variants are used as replacements outside of the S phase. One such example is the H3.3 histone variant that is expressed throughout the cell cycle ([@bib2]). The general localization patterns of H3.3, around the promoters and within the gene bodies of expressed genes, is consistent with the idea that H3.3 is deposited as a replacement histone at transcribed genes ([@bib16; @bib27; @bib38; @bib46]). Furthermore, a number of studies indicated that H3.3 is preferentially marked by modifications associated with active euchromatin and depleted of silencing modifications ([@bib18; @bib32]), leading to the notion that H3.3 is predominantly associated with transcription and is a marker for active chromatin. However, H3.3 also has been detected at pericentric heterochromatin (PCH) and telomeres, regions of silenced constitutive heterochromatin, and the role of H3.3 at these sites is currently unclear ([@bib10; @bib16; @bib47; @bib48]).

Intriguingly, the deposition of H3.3 into these two distinctive chromatin compartments appears to be dependent on two separate pathways. Deposition of H3.3 at euchromatin and bivalent-chromatin promoters is mediated by HIRA, an H3.3-specific histone chaperone ([@bib3; @bib16; @bib36]). Concordantly, HIRA shows strong co-localization with H3.3 and active histone modifications across the genome ([@bib16; @bib27; @bib34]), and HIRA knockouts (KOs) fail to deposit H3.3 at euchromatic sites in the genome, including promoters, gene bodies, and enhancers ([@bib16; @bib34]). In contrast, deposition of H3.3 at PCH and telomeres is dependent on a second complex comprised of Daxx and ATRX ([@bib10; @bib16; @bib48]). Both ATRX and Daxx are required for the deposition of H3.3 at these repeats, and mutations in the ATRX/Daxx/H3.3 pathway have been linked to certain cancers and an alternative lengthening of telomeres (ALT) phenotype ([@bib19; @bib23; @bib31; @bib39]), demonstrating the importance of this pathway in maintaining chromatin integrity and, with it, genomic stability.

In this study, we expanded on the role of the ATRX/Daxx complex in H3.3 deposition across the genome. Here we show that ATRX-dependent deposition of H3.3 is not limited to PCH and telomeres, but also occurs at other distinct heterochromatic regions dispersed throughout the genome, most notably at the silenced alleles of imprinted genes. Using these imprinted genes as a model, we demonstrate that ATRX-dependent deposition of H3.3 preferentially localizes to the DNA-methylated allele, indicating that this process must be driven epigenetically. Finally, we demonstrate that H3.3 deposition is crucial for the somatic maintenance of H3K9me3 at many constitutive heterochromatic regions, and we propose a role for this histone variant in maintaining the epigenetic memory of silenced heterochromatin.

Results {#sec2}
=======

ATRX and H3.3 Are Enriched at Heterochromatic Repeats throughout the Genome {#sec2.1}
---------------------------------------------------------------------------

Previously published data of validated ATRX chromatin immunoprecipitation sequencing (ChIP-seq) in mouse embryonic stem cells (ESCs) were obtained from the GEO database ([GSM551138](ncbi-geo:GSM551138){#intref0010}) ([@bib30]), and reads were aligned to genomic repeats using Repeats Enrichment Estimator ([@bib8]). Consistent with previous studies, ATRX was enriched at pericentric and telomeric repeats relative to input ([Figure 1](#fig1){ref-type="fig"}A; [@bib16; @bib30]). In addition, ATRX was enriched at a number of other genomic repeats ([Figure S1](#app3){ref-type="sec"}). As genomic repeats are known to be enriched for H3K9me3 and H4K20me3, chromatin modifications that are associated with heterochromatin, all ATRX-binding sites across the genome also were tested for association with these two repressive modifications.

ChIP-seq reads for ATRX, H3K9me3 ([GSM1375155](ncbi-geo:GSM1375155){#intref0015}) ([@bib6]), and H4K20me3 ([GSM656527](ncbi-geo:GSM656527){#intref0020}) were aligned to the genome with Bowtie ([@bib29]), and 1,643 ATRX-binding sites were identified in mouse ESCs. H3K9me3 and H4K20me3 ChIP-seq reads were quantitated under ATRX peaks and compared to random genomic fragments generated with RSA-tools (<http://rsat.ulb.ac.be/rsat/random-genome-fragments_form.cgi>; [Figure 1](#fig1){ref-type="fig"}B). Both H3K9me3 and H4K20me3 were enriched under ATRX-binding sites relative to random control regions, indicating that ATRX is consistently associated with these two heterochromatic modifications throughout the genome. This is also consistent with a recent study showing that the ATRX ADD domain is able to enrich for H3K9me2/3- and H4K20me2/3-modified nucleosomes ([@bib42]).

ATRX binding at pericentric and telomeric repeats has been linked to the deposition of the histone variant H3.3 into these regions ([@bib10; @bib16; @bib48]). Analysis of ChIP-seq results for histone H3.3 confirmed that this histone variant was enriched at telomeric and PCH ([Figure 1](#fig1){ref-type="fig"}C, left). Given the strong relationship between ATRX and H3.3 at repetitive heterochromatin, all ATRX-binding sites throughout the genome were profiled for H3.3 enrichment. Similar to the findings for H3K9me3 and H4K20me3, ATRX genomic targets were generally enriched for H3.3 relative to random genomic controls ([Figure 1](#fig1){ref-type="fig"}C, right). Intriguingly, ATRX-binding sites were found to be simultaneously enriched for the two histone marks of heterochromatin, H3K9me3 and H4K20me3, as well as for H3.3 ([Figure 1](#fig1){ref-type="fig"}D).

We next looked for primary DNA sequence features that might underlie ATRX-binding sites and found that ATRX primarily localizes to subsets of tandem repeats (n = 880) and endogenous retroviral (ERVK) repeats (n = 247) in mouse ESCs. In addition, ATRX was found to localize to CpG islands (CGIs) (n = 56) with a higher frequency than expected by chance, though CGI targets represent a relatively minor proportion of total ATRX peaks ([Figures 1](#fig1){ref-type="fig"}E and 1F). The majority of ATRX-binding sites in mouse ESCs therefore can be classified as binding either tandem repeats, ERVK repeats, or CGIs, which are enriched for heterochromatic modifications (H3K9me3/H4K20me3) and histone H3.3 ([Figure 1](#fig1){ref-type="fig"}F, bottom; [Figure S2](#app3){ref-type="sec"}).

ATRX Localizes to CGIs Associated with an Atypical Chromatin Signature {#sec2.2}
----------------------------------------------------------------------

ATRX-dependent deposition of histone H3.3 at telomeres and PCH has been described previously and the co-localization of H3K9me3 and H4K20me3 is consistent with the heterochromatic nature of these regions. We have now extended this association to other ATRX-binding sites, which, in the main, comprise interstitial repeats that also appear to form segments of heterochromatin.

In contrast, CGIs usually are associated with gene promoters, transcription, and modifications associated with active chromatin, and the association with ATRX is unexplained. We therefore decided to examine chromatin modifications associated with the identified ATRX-bound CGIs in more detail. Only 75 CGIs in the genome are overlapped by ATRX peaks, and in total 56 ATRX peaks that overlie CGIs were identified (some ATRX peaks overlie more than one CGI). Typical of ATRX targets, but unusual for CGIs, ATRX-bound CGIs were simultaneously enriched for H3K9me3, H4K20me3, and histone H3.3 ([Figures 2](#fig2){ref-type="fig"}A and 2C). In addition, half of the ATRX-bound CGIs were DNA methylated ([GSE28254](ncbi-geo:GSE28254){#intref0030}) ([@bib5]), a modification that is present at only 5% of CGIs genome wide ([Figure 2](#fig2){ref-type="fig"}B).

Sequential filters applied to CGIs across the genome isolated several factors associated with ATRX binding. Selecting for CGIs enriched for modifications associated with heterochromatin (DNA methylation, H3K9me3, and H4K20me3) increased the proportion of CGIs bound by ATRX ([Figure 2](#fig2){ref-type="fig"}D, left). Further selection for CGIs associated with H3.3 enrichment and active transcription (determined by RNA sequencing \[RNA-seq\]) increased the ATRX-bound fraction to 90% ([Figure 2](#fig2){ref-type="fig"}D, left). Assessment of ATRX peaks that overlapped CGIs showed that 28 of 56 (50%) of these ATRX peaks were not associated with promoters ([Table S1](#app3){ref-type="sec"}), compared to a genomic average of 23%. The majority (32 of 56) of ATRX-associated CGIs were found to be localized to intragenic regions and embedded within a transcriptional unit ([Table S1](#app3){ref-type="sec"}; [Figure 2](#fig2){ref-type="fig"}E), and they demonstrated a different profile of chromatin marks from those seen at promoter CGIs ([Figure 2](#fig2){ref-type="fig"}E, top). The ATRX-binding sites that overlapped CGI promoters showed minimal overlap between the peak of ATRX binding and the CGI, indicating these overlaps may represent a distinct subclass ([Figures S2](#app3){ref-type="sec"}D--S2F). ATRX binding therefore is associated with a particular subset of heterochromatin-modified intragenic CGIs, which also are enriched for H3.3 and transcribed.

Imprinted, Differentially Methylated Regions Are Enriched for ATRX, Heterochromatic Modifications, and H3.3 {#sec2.3}
-----------------------------------------------------------------------------------------------------------

Filtering for features associated with ATRX-bound CGIs also led to an enrichment for imprinted loci ([Figure 2](#fig2){ref-type="fig"}D, right; [Table S1](#app3){ref-type="sec"}). Imprinted genes are specialized genes that are expressed in a monoallelic fashion, depending on the parental origin of the allele. There are an estimated 150 imprinted genes in the mouse genome, most of which are arranged in chromosomal clusters ([@bib45]). The imprinted expression pattern of multiple genes within a cluster can be controlled by single imprinting control region (ICR). These specialized regions, which commonly have the characteristics of CGIs, are marked by DNA methylation on one of the two parental alleles. As this differential DNA methylation originates from one of the two germlines, these regions are referred to as germline differentially methylated regions (DMRs). Enrichment of ATRX was found at 12 of the 17 germline DMR regions that have been identified in the mouse genome thus far ([Table 1](#tbl1){ref-type="table"}), and modest ATRX enrichment (although not peak-called) was detected at an additional three germline DMRs ([Figure S3](#app3){ref-type="sec"}). In addition, ATRX binding was detected at four imprinting-associated somatic DMRs, meaning that ATRX peaks were seen at 16 of 21 (80%) of these highly specialized regions of the genome ([Table 1](#tbl1){ref-type="table"}); 13 of these were included in the list of ATRX-bound CGIs ([Table S1](#app3){ref-type="sec"}). Interestingly, the two DMRs that lacked any detectable enrichment of ATRX, *Gnas* and *Slc38a4*, also were depleted of other factors (H3K9me3, H4K20me3, and H3.3) associated with ATRX binding. ATRX enrichment at selected imprinted regions was further confirmed by ChIP qPCR in wild-type (WT) versus ATRX KO mouse ESCs ([Figure S4](#app3){ref-type="sec"}A), and examples of these sites are shown ([Figure S4](#app3){ref-type="sec"}B).

ATRX localization at these regions coincided with enrichment for heterochromatic modifications and histone H3.3 ([Table 1](#tbl1){ref-type="table"}; [Figure 3](#fig3){ref-type="fig"}A, top). All ICRs and DMRs across the genome were associated with DNA methylation, generally high levels of H3K9me3 and H3.3, and mid-to-high levels of H4K20me3 ([Table 1](#tbl1){ref-type="table"}), the same chromatin signature linked to ATRX. This means imprinted regions are linked with both ATRX binding and its associated chromatin signature, implying a specialized function for this particular combination of chromatin marks in the genome.

ATRX and Histone H3.3 Preferentially Localize to the Methylated Allele of Imprinted DMRs {#sec2.4}
----------------------------------------------------------------------------------------

Imprinted DMRs in the genome are characterized by differential chromatin modifications, depending on the parental origin of the allele ([@bib13; @bib24; @bib37; @bib40]). In general, one parental allele is modified with DNA methylation and histone modifications associated with silenced heterochromatin, while the other allele is modified with marks of active chromatin, such as H3K4me3, associated with promoter activity on this parental allele. Screenshots of selected imprinted DMRs in the mouse genome ([Figure 3](#fig3){ref-type="fig"}A, top) illustrate some of the chromatin modifications that are known to be associated with these regions. Importantly, as ChIP-seq does not normally distinguish between alleles, the active (H3K4me3) and heterochromatic (DNA methylation, H3K9me3, and H4K20me3) modifications appear to overlap at these regions, although these modifications are known to be distributed allelically ([@bib13; @bib33; @bib40]).

Given that ATRX, through its ADD domain, is capable of recognizing H3K9me3 ([@bib9; @bib12; @bib20]) while H3.3 is widely associated with active chromatin, we wondered if these two proteins also might be allelically distributed. This can be investigated using cells derived from F1 offspring of parental mouse strains that harbor distinctive SNPs, such as an inbred female SV129 crossed to an outbred *Mus m. castaneus* male (SV129 × Cast F1). Publically available ChIP-seq of H3K4me3 ([GSM307605](ncbi-geo:GSM307605){#intref0035}) and H3.3 ([GSM487542](ncbi-geo:GSM487542){#intref0040}) in mouse ESCs derived from a SV129 × Cast cross were obtained and aligned to the mouse genome. Reads that spanned an informative SNP at relevant imprinted DMRs were extracted and assigned to either the maternal or paternal allele. H3K4me3 reads primarily localized to the unmethylated allele, as previously reported, but, unexpectedly, H3.3 reads were consistently found to be biased toward the opposite, DNA-methylated allele ([Figure 3](#fig3){ref-type="fig"}A, bottom).

This finding was further confirmed by performing ChIP against ATRX, H3.3, H3K9me3, and the activating H3K4me3 modifications in mouse ESCs derived from a similar female SV129 × Cast male cross. Resulting ChIP products were amplified with primers designed around polymorphic SNPs, and PCR products were digested with restriction enzymes specific for either the maternal or paternal allele. A number of imprinted loci were tested and digestion patterns were compared to input controls ([Figure 3](#fig3){ref-type="fig"}B; [Figures S4](#app3){ref-type="sec"}C--S4F). In agreement with previous studies ([@bib13; @bib40]), the heterochromatic H3K9me3 modification preferentially localized with the reported DNA-methylated allele, while the active H3K4me3 modification localized to the opposite unmethylated allele.

As predicted, ATRX was found to co-localize with the H3K9me3-modified methylated allele, and, intriguingly, H3.3 also was enriched on the DNA-methylated allele. Digestion patterns of H3.3 ChIP PCR products were more similar to H3K9me3 and ATRX than H3K4me3 patterns at all polymorphic imprinted DMRs tested ([Figure 3](#fig3){ref-type="fig"}B; [Figures S4](#app3){ref-type="sec"}C--S4F). Therefore, ATRX and H3.3 both localize preferentially with the heterochromatic H3K9me3, DNA-methylated allele at imprinted DMRs.

ATRX Is Required for H3.3 Deposition and H3K9me3 at Imprinted DMRs in the Genome {#sec2.5}
--------------------------------------------------------------------------------

Given that ATRX is necessary for the correct deposition of H3.3 at PCH and telomeres, we wondered if ATRX also might be necessary for the deposition of H3.3 at imprinted loci. ChIP-seq of H3.3 was performed in WT and ATRX KO mouse ESCs, and ATRX-binding sites were assessed for H3.3 enrichment. Consistent with previous reports, genomic CGIs, which generally are associated with promoters, were found to be moderately enriched for H3.3 compared to random genomic fragments ([Figure 4](#fig4){ref-type="fig"}A). However, ATRX-bound imprinted DMRs were found to be strikingly enriched for H3.3 in WT cells, and enrichment was lost in the absence of ATRX ([Figure 4](#fig4){ref-type="fig"}A). This profile of H3.3 enrichment in WT cells and subsequent depletion in ATRX KO cells was not restricted to ATRX-associated imprinted DMRs, but appeared to be a general feature associated with ATRX binding throughout the genome ([Figures S5](#app3){ref-type="sec"}A--S5D).

Examples of the chromatin profiles of WT ESCs at a number of imprinted DMRs and the loss of H3.3 in ATRX KO cells are shown in [Figure 4](#fig4){ref-type="fig"}B. This unique chromatin profile is limited specifically to imprinted DMRs, since the canonical promoter CGIs of imprinted genes do not bind ATRX and are unaffected in ATRX KO cells ([Figure 4](#fig4){ref-type="fig"}C). Furthermore, promoter-associated CGIs in general, which are marked with H3K4me3 ([Figure 4](#fig4){ref-type="fig"}D), retain comparable levels of H3.3 enrichment in ATRX KO cells ([Figures 4](#fig4){ref-type="fig"}A and 4D).

ChIP qPCR of H3.3 at a number of imprinted DMRs in WT and ATRX KO cells was used to confirm the loss of H3.3 at these sites in the absence of ATRX ([Figure 4](#fig4){ref-type="fig"}E). As these sites also were enriched for H3K9me3 ([Figure 4](#fig4){ref-type="fig"}B) and ATRX is known to be associated with this modification, we profiled H3K9me3 in the presence and absence of ATRX. Unexpectedly, we found that loss of ATRX also led to the loss of H3K9me3 at all imprinted DMRs tested ([Figure 4](#fig4){ref-type="fig"}F). In addition, we profiled a number of non-imprinted ATRX intragenic CGI targets and found a similar situation where ATRX KO led to the loss of both H3.3 and H3K9me3 enrichment at these sites ([Figures S5](#app3){ref-type="sec"}E and S5F). All non-imprinted CGIs profiled were DNA methylated and modified as heterochromatin and located within the intragenic regions of transcribed genes. Furthermore, analysis of DNA methylation at imprinted DMRs in mouse ESCs also demonstrated an erosion of methylation at these sites in ATRX KO cells ([Figure S5](#app3){ref-type="sec"}G).

Taken together, these data suggest that ATRX-bound intragenic CGIs, including imprinted DMRs, have a unique requirement for ATRX-mediated deposition of H3.3 and that these interactions are necessary for the maintenance of H3K9me3 at these sites.

ATRX/H3.3/H3K9me3 Are Required for the Silencing of Numerous Imprinted Genes {#sec2.6}
----------------------------------------------------------------------------

Imprinted genes are characterized by monoallelic expression in a parent-of-origin-dependent manner, and imprinted expression is thought to be dependent on chromatin modifications, particularly DNA methylation, associated with the ICRs and DMRs ([@bib4; @bib44]). As H3K9me3 is linked to DNA methylation and gene silencing, we sought to determine if loss of ATRX and associated loss of H3.3 and H3K9me3 at these sites would lead to aberrant parental expression of imprinted genes.

To assess this, female SV129 mice carrying a floxed allele of the X chromosome-linked *ATRX* gene ([@bib14]) were crossed with castaneus males to generate a male (SV129 × Cast) F1 ESC line, which would allow allelic discrimination. The SV129 × Cast ATRX^*Flox*^ ESCs were transduced with an adenoviral Cre-GFP cassette (AdCre) to generate ATRX KO cells. An adenoviral GFP cassette (AdGFP) was used as a negative control. Cells were sorted for GFP expression and RNA was extracted for sequencing. ATRX KO was confirmed by genotyping PCR ([Figure S6](#app3){ref-type="sec"}A), real-time PCR for ATRX expression ([Figure S6](#app3){ref-type="sec"}B), and RNA-seq data ([Figure S6](#app3){ref-type="sec"}C). RNA was separated into PolyA+ and PolyA− fractions to capture both stable and unstable transcripts, and both fractions were subjected to strand-specific RNA-seq. Reads were aligned to the genome, and reads spanning an informative SNP were extracted and assigned to parental genomes using customized Perl scripts ([Table S4](#app3){ref-type="sec"}). Only genes with more than 50 informative SNP reads were considered for analysis.

A control dataset of 1,500 random genes were assessed for parental skewing ([Table S4](#app3){ref-type="sec"}), and the average parental skew was found to be 50% in the PolyA+ fraction and 54% in the PolyA− fraction toward SV129. The 150 imprinted genes (<http://www.har.mrc.ac.uk/research/genomic_imprinting/>) were assessed for allelic skewing ([Table S4](#app3){ref-type="sec"}). Within the PolyA− fraction, 11 genes showed \>66% skewing toward the expected parental allele and one gene was skewed \>60% toward the expected parental allele ([Figure 5](#fig5){ref-type="fig"}A). Within the PolyA+ fraction, a total of 12 genes showed \>66% skewing toward the expected parental allele, while an additional four genes were skewed \>60% toward the expected parental allele ([Figure 5](#fig5){ref-type="fig"}B).

Focusing on 18 non-redundant genes that demonstrated allelic biases consistent with the literature, we examined their parental read distribution in the ATRX KO (AdCre) dataset. Five of 18 imprinted genes analyzed demonstrated \>10% disruption in allelic distribution patterns in ATRX KO cells ([Figure 5](#fig5){ref-type="fig"}A), with particular disruptions occurring at the ATRX-bound methylated allele ([Figures S6](#app3){ref-type="sec"}D--S6G). These results were broadly reproducible across a second independent experiment ([Figures S6](#app3){ref-type="sec"}H and S6I), with the more stable PolyA+ fraction demonstrating a higher degree of reproducibility.

One example of an imprinted locus is illustrated in [Figure 5](#fig5){ref-type="fig"}C. At the *Commd1/Zrsr1* locus, the *Commd1* gene is expressed from the maternal allele, and the *Zrsr1* promoter, which is intragenic with respect to *Commd1*, is methylated on the SV129 maternal allele. Data from previous experiments indicate that ATRX, H3.3, and H3K9me3 also are localized to the maternal SV129 allele. On the reciprocal paternal allele, *Commd1* is silent and *Zrsr1* is unmethylated and expressed. RNA-seq data confirmed *Zrsr1* is preferentially expressed from the Castaneus paternal allele ([Figure 5](#fig5){ref-type="fig"}B), while the expression from the maternal SV129 allele is suppressed. In ATRX KO cells, there is a substantial increase in *Zrsr1* reads originating from the SV129 maternal allele compared to WT cells ([Figure 5](#fig5){ref-type="fig"}C). This suggests that loss of ATRX leads to the loss of H3.3 and H3K9me3 and results in the de-repression of the normally silenced maternal SV129 *Zrsr1* allele.

In total, five genes demonstrated \>10% disruption in allelic distributions across four imprinted loci; Commd1/Zrsr1, Nespas, Sgce, and Trappc9 ([Figures S6](#app3){ref-type="sec"}D--S6G). Where appropriate, the reads for the overlapping gene partner also have been illustrated. This indicates that aberrant allelic expression is a general feature associated with the loss of ATRX at these sites ([Figures S6](#app3){ref-type="sec"}D--S6G).

Discussion {#sec3}
==========

Histone H3.3 is a replication-independent histone variant ([@bib2]) that is indispensable in mammalian development ([@bib7]). Numerous studies have indicated that H3.3 primarily is associated with transcription ([@bib16; @bib27; @bib38; @bib46]) and is enriched for modifications associated with euchromatin ([@bib18; @bib32]). The deposition of H3.3 into these euchromatic regions is dependent on the HIRA chaperone complex ([@bib36]), and HIRA KO leads to the loss of H3.3 at these sites ([@bib16; @bib34]). However, histone H3.3 also is associated with a second chaperone complex, ATRX/Daxx, which is required for the deposition of H3.3 into PCH and telomeres, regions that are considered constitutive heterochromatin ([@bib10; @bib16; @bib48]). In this study, we show that this association is not limited to PCH and telomeres, but also applies to distinct heterochromatic regions distributed throughout the genome where the presence or absence of ATRX has important functional consequences on gene silencing.

Genome-wide analysis of ATRX-binding sites showed that these were enriched for both heterochromatic marks (H3K9me3 and H4K20me3) and H3.3. Among these were short tandem repeats and intragenic CGIs, which included many imprinted DMRs. Here we chose to focus on the CGI targets of ATRX. In addition to enrichment for H3K9me3 and H4K20me3, ATRX-bound CGI sequences were also more likely to be methylated than the genomic average. The overwhelming majority of annotated CGIs in the genome localized to gene promoters and were enriched for either H3K4me3 or H3K27me3 in a manner that reflects gene expression. In contrast, ATRX-bound CGIs tended to localize within gene bodies, and the atypical chromatin profile observed at these sites likely could be attributed to this genomic position. However, as these heterochromatic CGIs lie within active genes, these regions are nonetheless transcribed, and our data suggest that transcription per se is a factor that positively selects for ATRX binding. As H3.3 is known to act as a replacement histone (reviewed in [@bib11]), this link to transcription and the associated nucleosomal turnover could partially explain the presence of H3.3 within these intragenic regions.

H3.3 is generally considered a mark of active chromatin, and, consistent with this, we found co-localization of H3.3 with H3K4me3-modified promoters within our dataset. The deposition of H3.3 into gene-rich regions is thought to be predominantly dependent on HIRA ([@bib34; @bib36]) rather than the ATRX/Daxx complex, a finding that is also generally consistent with our data. We found that H3.3 was moderately enriched at CGI promoters across the genome and this enrichment was unaffected in ATRX KO cells, confirming that H3.3 deposition at these regions was generally independent of ATRX. However, the ATRX-bound CGIs identified in this study represent distinct exceptions to this general pattern. At these particular heterochromatin-modified regions, ATRX binding coincided with unusually high enrichment for H3.3 and deposition of H3.3 failed to occur in the absence of ATRX. Interestingly, the CGIs that were positive for all the features associated with ATRX binding also included a substantial number of imprinted DMRs.

ATRX previously has been reported as being involved in silencing at imprinted loci, but in these reports ATRX was required for developmental silencing of the active allele in post-natal brain ([@bib25; @bib26]). Quite separate from this phenomenon, we showed here that, in mouse ESCs, ATRX acts to maintain the differential expression of the alleles at imprinted loci. We found that at the majority of DMRs in mouse ESCs, the silenced alleles were enriched for marks of constitutive heterochromatin, ATRX, and histone H3.3. The imprinted DMRs represent a unique and functionally distinct set of genomic targets. At these developmentally essential regions, though the two parental alleles are genetically identical, they carry distinct combinations of chromatin modifications ([@bib24; @bib37; @bib40]; reviewed in [@bib44]). Thus, imprinted DMRs represent an excellent in vivo model system for assessing chromatin-driven ATRX binding. Allelic discrimination assays at these sites showed that both ATRX and H3.3 were preferentially localized to the DNA-methylated/H3K9me3-modified allele, rather than the H3K4me3-modified allele, at many of the imprinted DMRs. This indicates that epigenetic factors play an important role in targeting ATRX-dependent deposition of H3.3 at imprinted loci in this cellular context.

We previously noted that ATRX-bound CGIs were localized to intragenic regions rather than promoters. However, at imprinted DMRs, these features were not mutually exclusive. A number of imprinted genes were arranged in overlapping transcription pairs, whereby the promoter of one gene was intragenic with respect to a second transcriptional unit. In fact, this pattern of overlapping antisense-oriented transcription is thought to be important for the establishment of imprinting at many loci (reviewed in [@bib4]). Using the *Commd1/Zrsr1* locus as an example, the maternally methylated DMR is intragenic with respect to *Commd1* transcription, but, on the unmethylated paternal allele, the same CGI acts as a promoter for *Zrsr1* expression. Therefore, it is likely that the heterochromatin islet at the maternal *Commd1* intragenic CGI suppresses expression of *Zrsr1* from this allele. However, the process of transcription through *Commd1* is predicted to disrupt the heterochromatin-modified nucleosomes at this intragenic CGI, and, in the absence of active maintenance, could potentially lead to the erosion of modifications at this site over time. Results from this study indicate that ATRX-dependent deposition of H3.3 plays a key role in maintaining the heterochromatic modifications at these sites, as loss of ATRX leads to the loss of both H3.3 and H3K9me3 at imprinted DMRs and results in aberrant allelic expression of a number of imprinted genes. Although we observed only modest changes in gene expression in our acute KO model of ATRX, H3.3 KO has been shown to result in changes in expression of imprinted genes ([@bib3; @bib7]). ATRX KO in SV129 × Cast ESCs was lethal and, therefore, it was not possible to assess these effects in long-term culture or mouse models. Nonetheless, these data identify ATRX as a regulator of genomic imprinting in this ESC model.

The preferential localization of ATRX and H3.3 to the DNA-methylated allele of many imprinted DMRs indicates that the chromatin environment is an important factor in determining whether ATRX is recruited for the deposition of H3.3. A similar situation was observed at several non-imprinted CGIs located at intragenic regions of actively transcribed genes. These intragenic CGIs were also DNA methylated and marked as heterochromatin, and localization of ATRX to these sites further supports the idea of chromatin-driven binding. Finally, we showed a decrease in both H3.3 and H3K9me3 at these sites in the absence of ATRX, which, in turn, led to aberrant allelic expression. This finding may have broader implications for ATRX-dependent deposition of H3.3 at other genomic sites, such as telomeres, where loss of ATRX and H3.3 also may lead to the loss of heterochromatic modifications.

We hypothesize that ATRX localizes to distinct heterochromatic regions when these sites are subjected to nucleosomal disruptions and that ATRX/Daxx helps to facilitate the timely deposition of H3.3. The presumption is that ATRX/Daxx then leads to the recruitment of other factors, including histone lysine methyltransferase(s) such as Eset/Setdb1/Kmt1e, which controls the H3K9me3 at imprinted DMRs ([@bib15; @bib49]) that can modify the newly deposited replacement histones, thus ensuring the faithful somatic maintenance of silencing modifications ([Figures 6](#fig6){ref-type="fig"}A--6C). In the absence of ATRX, H3.3 is no longer deposited at its target loci. This is associated with the loss of H3K9me3, de-repression, and aberrant transcription of the genes involved ([Figure 6](#fig6){ref-type="fig"}D). The recruitment of ATRX to these sites is most likely driven by the combinatorial interaction of ATRX with both H3K9me3 and HP1 ([@bib12; @bib20]) and transcription. At the heterochromatic allele of imprinted DMRs, the Eset-mediated H3K9me3 is recognized by HP1γ ([@bib33]), and our recent studies suggest Eset can interact with ATRX, at least in vitro (data not shown). This would provide a reinforcing feedback loop in which the ATRX-mediated incorporation of H3.3 and its ensuing methylation of lysine-9 facilitate the recruitment of ATRX to the heterochromatic regions involved.

Experimental Procedures {#sec4}
=======================

GEO Datasets {#sec4.1}
------------

A list of GEO datasets used in this study can be found in [Table S5](#app3){ref-type="sec"}.

ChIP {#sec4.2}
----

ATRX and Daxx ChIP were performed as previously described ([@bib30]). In brief, cells were fixed in PBS with 2 mM EGS (Pierce 26103) for 45 min at room temperature followed by 1% formaldehyde for 20 min. Chromatin was sonicated to \<500 bp and lysates were immunoprecipitated with 10 μg ATRX H300 (Insight Biotechnology sc-15408), 10 μg Daxx M-112 (Santa Cruz Biotechnology sc-7152), or rabbit IgG control (Dako X0903). Histone ChIPs were performed according to the manufacturer's instructions (Millipore 17-295) using either 10 μg H3.3 antibody (Millipore 09-838), 5 μg H3K9me3 antibody (Abcam ab8898), or 2 μg H3K4me3 antibody (Abcam ab8580).

ChIP-Seq Analysis {#sec4.3}
-----------------

Fastq files were aligned to the mouse (mm9) genome with Bowtie (v1.0.0) ([@bib29]) using default settings, except that reads were allowed to match the genome up to five times to facilitate mapping to repeats. ATRX peak calls were performed in Seqmonk (v0.24.1) (<http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/>), and reads associated with histone modifications were quantitated under ATRX peaks after normalizing for total mapped reads. Further details are provided in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Repeats Analysis {#sec4.4}
----------------

Fastq files were aligned to genomic repeats using Repeat Enrichment Estimator v1.0. Mapped reads were normalized for total read count and compared to input samples. Repeats with less than 50 mapped reads were excluded from further analysis. Repeat classes were considered enriched for protein binding if ChIP-seq reads exceeded input reads by more than 2-fold after normalizing for total read counts.

Identification of SNPs in ChIP-Seq Reads {#sec4.5}
----------------------------------------

ChIP-seq data of H3K4me3 ([GSM307605](ncbi-geo:GSM307605){#intref0055}) and H3.3 ([GSM487542](ncbi-geo:GSM487542){#intref0060}) in female SV129 × Castaneus male F1 ESCs were obtained from GEO. SNPs that differed between these two strains were obtained from The Mouse Genomes Project at the Wellcome Trust Sanger Institute webpage (<https://www.sanger.ac.uk/resources/mouse/genomes/>). ChIP-seq reads were mapped using Bowtie and reads that overlapped DMRs were extracted. As the IG-DMR was significantly broader than the ATRX-binding site, only reads underlying the ATRX peak were extracted from this region. DMR reads were overlapped with SNPs and parental SNPs were identified using custom Perl scripts (available upon request).

Allelic Discrimination Assays {#sec4.6}
-----------------------------

ATRX-bound DMRs were assessed for differential SNPs that created a differential restriction site. Primers were designed around appropriate sites and used to amplify ChIP DNA. PCRs were performed using Expand High-Fidelity Taq (Roche 11732641001) according to the manufacturers' instructions. ChIP or input DNA (1 μl) was amplified in a 50-μl reaction for 40 cycles with an annealing temperature of 55°C. Equal amounts of PCR products were subjected to restriction digest and separated on a 2.5% agarose gel. Digestion products were visualized using Sybr Gold (Life Technologies S-11494). Digested PCR products were quantified in ImageJ and allelic enrichments were calculated relative to input. A list of primers used in this study can be found in [Table S2](#app3){ref-type="sec"}.

Real-Time qPCR {#sec4.7}
--------------

Real-time qPCR was performed using SYBR green mastermix (Applied Biosystems 4309155). ChIP enrichments were determined relative to a three-point dilution series of input DNA and normalized relative to GAPDH enrichment. A list of primers used in this study can be found in [Table S3](#app3){ref-type="sec"}.

Generation of SV129 × Castaneus ATRX KO ESCs {#sec4.8}
--------------------------------------------

SV129 females carrying an ATRX^*Flox*^ cassette ([@bib14]) were mated with Castaneus males and ESCs were derived from male ATRX^*Flox*^ embryos. An adenoviral-packaged Cre-recombinase cassette with a GFP marker (Vector Laboratories 1779) (AdCre) was used to generate ATRX KO ESCs. An adenoviral-packaged eGFP cassette (AdGFP) was used as a negative control (Vector Laboratories 1768). One million ESCs were seeded in a T25 flask and transduced with 1 × 10^8^ plaque-forming units (PFU) of either AdCre or AdGFP adenovirus in 10 ml media. Transduced cells were recovered for 48 hr and then subjected to fluorescence-activated cell sorting (FACS) for GFP expression. AdCre GFP-positive cells were confirmed as ATRX KO by genotyping PCR and qPCR for ATRX expression. AdGFP-positive cells were retained as a negative control.

RNA Extraction and Sequencing {#sec4.9}
-----------------------------

RNA was extracted at 5 days post-transduction with Tri-Reagent (Sigma-Aldrich T9424). Total RNA was separated using a PolyATtract mRNA Isolation System (Promega Z5310). The rRNA was removed from PolyA− fractions with a Ribo-Zero Magnetic Kit (EpiCentre MRZH11124). Libraries were created using NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England Biolabs E7420L) with minor modifications ([@bib28]), and sequenced on a HiSeq2500 in rapid mode to generate 50 bp paired-end reads.

Allelic RNA-Seq Analyses {#sec4.10}
------------------------

RNA-seq data were aligned to the mm9 genome with TopHat v2.0.10 ([@bib43]) using default parameters. Parental SNPs across genes were identified as previously described for ChIP-seq datasets, except that reads were analyzed in a strand-specific manner. RNA-seq reads also were extracted from 1,500 random genes and used to assess the distribution of parental SNPs. Only genes with more than 50 informative SNP reads were included in the analysis.

Author Contributions {#sec5}
====================
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![ATRX Localizes to Genomic Regions that Are Enriched for Heterochromatic (H3K9me3/H4K20me3) Modifications and Histone H3.3\
(A) ATRX ChIP-seq reads are mapped to genomic repeats and normalized for total read count compared to input.\
(B) (Left) H3K9me3 and (right) H4K20me3 are enriched under ATRX peaks compared to random genomic fragments. H3K9me3 and H4K20me3 ChIP-seq reads were quantitated under ATRX peaks and normalized for total read counts. Normalized read counts under random genomic fragments were used as a control. Boxes represent the 25^th^, median, and 75^th^ percentiles; whiskers represent the 90^th^ and 10^th^ percentiles.\
(C) (Left) H3.3 ChIP-seq reads are mapped to genomic repeats and normalized for total read count compared to input. (Right) H3.3 ChIP-seq quantitation under ATRX peaks are normalized for total read count.\
(D) Overlap between heterochromatic H3K9me3 and H4K20me3 marks and histone H3.3 under ATRX peaks. Enrichment is defined as normalized read counts \>75^th^ percentile of random genomic fragments. Overlap of H3K9me3/H4K20me3/H3.3 enrichments in random fragments of the genome is shown as a control.\
(E) ATRX is enriched at tandem repeats (TRs), ERVK elements, and CGIs (CGI) in the genome relative to random genomic fragments.\
(F) Proportion of ATRX-binding sites that overlie CGI, TRs, ERVK, and heterochromatin. See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![ATRX-Bound CGI Are Enriched for Marks of Heterochromatin (H3K9me3/H4K20me3 and DNA Methylation) and H3.3\
(A) Normalized read counts of (left) H3K9me3, (middle) H4K20me3, and (right) H3.3 ChIP-seq at ATRX-bound CGI relative to genomic CGI are shown. Boxes represent the 25^th^, median, and 75^th^ percentiles; whiskers represent the 90^th^ and 10^th^ percentiles.\
(B) Proportion of CGI that are methylated genome-wide in comparison to ATRX-bound CGI is shown.\
(C) Overlapping enrichment profiles of H3K9me3, H4K20me3, and H3.3 under ATRX CGI compared to genomic CGI are shown.\
(D) (Left) Proportion of CGI that are bound by ATRX following sequential filtering for DNA methylation, H3K9me3/H4K20me3 enrichment, H3.3 enrichment, and active transcription is shown. (Right) Proportion of CGI that are associated with imprinting and ATRX after sequential filtering is shown.\
(E) Screenshots of the (top) *Spred2* locus, (bottom left) *Zfp629* locus, and (bottom right) *Zfp787* locus show a typical promoter CGI marked by high H3K4me3 and mid-level H3.3 compared to an ATRX-bound intragenic CGI, which is enriched with marks of heterochromatin (DNA methylation, H3K9me3, and H4K20me3) and H3.3. See also [Figure S2](#app3){ref-type="sec"}.](gr2){#fig2}

![ATRX Localizes Specifically to Methylated DMR in Imprinted Regions along with Histone H3.3 and ATRX and H3.3 Both Localize Specifically to the Methylated Allele\
(A) (Top) Screenshots show overlapping chromatin modifications at imprinted DMRs. Imprinted DMRs are simultaneously enriched for H3K4me3-activating marks and heterochromatic marks (DNA methylation, H3K9me3, and H4K20me3). ATRX and H3.3 also are enriched at these regions. (Bottom) Allelic distribution of H3.3 and H3K4me3 is shown. ChIP-seq reads of H3.3 and H3K4me3 in F1 Cast × 129 mouse ESCs with informative SNPs were assigned to either maternal or paternal alleles.\
(B) Allele specific localization of ATRX, H3K9me3, H3.3, and H3K4me3 at (top left) *Peg13*, (top right) *Peg3*, (bottom left) *Nap1L5*, and (bottom right) IG-DMR. ChIP products were PCR amplified and digested with allele-specific restriction enzymes. Products were separated by agarose gel electrophoresis. See also [Figure S4](#app3){ref-type="sec"}.](gr3){#fig3}

![ATRX Is Required for Correct Deposition of H3.3 and H3K9me3 at DMRs\
(A) Normalized read counts of H3.3 ChIP-seq in WT versus ATRX KO mouse ESCs at various genomic regions. ATRX-bound imprinted DMRs are highly enriched for H3.3 and enrichment is lost in the absence of ATRX. Boxes represent the 25^th^, median, and 75^th^ percentiles; whiskers represent the 90^th^ and 10^th^ percentiles.\
(B) Screenshots show the (left) *Igf2r/Airn*, (middle) *Trappc9/Peg13*, and (right) *Nap1L5/Herc3* DMRs that are enriched for H3.3 in WT cells and lose H3.3 in ATRX KO cells.\
(C) Screenshot shows the *Trappc9* promoter that retains H3.3 in ATRX KO cells.\
(D) Screenshot of a genomic region (chr17:13,021,841-13,220,327) shows a number of promoters that are enriched for H3K4me3 and H3.3 in WT cells. H3.3 profiles are unchanged in the ATRX KO cells.\
(E and F) Relative enrichment of (E) H3.3 and (F) H3K9me3 at DMRs in WT and ATRX KO mouse ESCs. ChIP products were amplified by qRT-PCR and enrichment was calculated relative to GAPDH after normalizing for input. Results represent the mean and SD of three independent experiments. See also [Figure S5](#app3){ref-type="sec"}.](gr4){#fig4}

![Allelic Read Distribution at Imprinted Genes Is Disrupted in ATRX KO Cells\
(A and B) RNA-seq of WT and ATRX KO ESCs show skewed distribution of reads at a number of imprinted genes in the (A) PolyA− and (B) PolyA+ fractions in WT cells. Genes where allelic distribution differed by \>10% in ATRX KO compared to WT cells are indicated in red. Allelic distribution of reads across randomly chosen genes in the genome are shown for comparison. Error bars represent SD of allelic skewing across the random dataset.\
(C) (Left) A schematic representation of the Zrsr1/Commd1 imprinted locus shows allelic expression and methylation patterns. (Right) Normalized read counts arise from the maternal SV129 Zrsr1 allele in WT and ATRX KO cells. See also [Figure S6](#app3){ref-type="sec"}.](gr5){#fig5}

![ATRX-Mediated Deposition of H3.3 Maintains Heterochromatic Profiles during Transcription\
(A) Schematic depiction of a gene containing a gene body CGI. Heterochromatic modifications such as H3K9me3 silence the internal CGI to prevent cryptic transcription.\
(B) Progression of RNA Pol II during transcription disrupts heterochromatin-modified nucleosomes at the internal CGI.\
(C) ATRX/Daxx mediate deposition of replacement H3.3 at the heterochromatic CGI and facilitate maintenance of chromatin modifications at this site.\
(D) Loss of ATRX leads to failure of H3.3 deposition, loss of chromatin modifications, and aberrant transcription.](gr6){#fig6}

###### 

Germline Somatic DMRs Associated with Genomic Imprinting Are Frequently Bound by ATRX

  DMR             Chr         Start       End             Feature    Description                           CpGi                                  Methylated                             ATRX   H3.3[c](#tblfn3){ref-type="table-fn"}   Daxx[c](#tblfn3){ref-type="table-fn"}   H3 K9me3[c](#tblfn3){ref-type="table-fn"}   H4 K20me3[c](#tblfn3){ref-type="table-fn"}   H3 K4me3[c](#tblfn3){ref-type="table-fn"}   H3 K27me3[c](#tblfn3){ref-type="table-fn"}
  --------------- ----------- ----------- --------------- ---------- ------------------------------------- ------------------------------------- -------------------------------------- ------ --------------------------------------- --------------------------------------- ------------------------------------------- -------------------------------------------- ------------------------------------------- --------------------------------------------
  Germline DMRs   chr1        63246988    63247117        Zdbf2      maternal                              no[a](#tblfn1){ref-type="table-fn"}   yes                                    yes    mid                                     mid                                     high                                        low                                          mid                                         low
  chr2            174119625   174123318   Nespas-Gnasxl   maternal   yes                                   yes                                   yes                                    mid    high                                    high                                    high                                        low                                          high                                        
  chr2            174152576   174154820   Gnas            maternal   yes                                   yes                                   no                                     mid    mid                                     mid                                     mid                                         low                                          high                                        
  chr6            4695857     4699483     Peg10           maternal   yes                                   yes                                   mid[b](#tblfn2){ref-type="table-fn"}   high   mid                                     high                                    high                                        mid                                          mid                                         
  chr6            30684007    30689966    Peg1            maternal   yes                                   yes                                   yes                                    high   high                                    high                                    mid                                         mid                                          mid                                         
  chr7            6680055     6685400     Peg3            maternal   yes                                   yes                                   yes                                    high   high                                    high                                    mid                                         low                                          mid                                         
  chr7            67148447    67150182    Snrpn           maternal   no[a](#tblfn1){ref-type="table-fn"}   yes                                   yes                                    high   mid                                     high                                    low                                         mid                                          low                                         
  chr7            149765988   149768095   H19             paternal   no[a](#tblfn1){ref-type="table-fn"}   yes                                   yes                                    mid    mid                                     high                                    mid                                         low                                          mid                                         
  chr7            150479567   150482810   Lit1/Kcnq1ot1   maternal   yes                                   yes                                   mid[b](#tblfn2){ref-type="table-fn"}   high   high                                    high                                    high                                        mid                                          mid                                         
  chr9            89771586    89778464    Rasgrf1         paternal   no[a](#tblfn1){ref-type="table-fn"}   yes                                   mid[b](#tblfn2){ref-type="table-fn"}   high   mid                                     mid                                     low                                         low                                          high                                        
  chr10           12809849    12811804    Zac1            maternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        mid                                          high                                        
  chr11           11925463    11927100    Meg1/Grb10      maternal   yes                                   yes                                   yes                                    high   mid                                     high                                    high                                        low                                          high                                        
  chr11           22871974    22872993    Commd1          maternal   yes                                   yes                                   yes                                    high   high                                    mid                                     high                                        mid                                          low                                         
  chr12           110765047   110769203   IG-DMR          paternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        mid                                          mid                                         
  chr15           96884878    96885292    Slc38a4         maternal   no[a](#tblfn1){ref-type="table-fn"}   no                                    no                                     mid    mid                                     mid                                     mid                                         mid                                          mid                                         
  chr17           12934169    12935733    Igf2r/Airn      maternal   yes                                   yes                                   yes                                    high   mid                                     high                                    mid                                         low                                          high                                        
  chr18           13130435    13133135    Impact          maternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        high                                         low                                         
  Somatic DMRs    chr2        157385786   157386317       Nnat       maternal                              yes                                   yes                                    yes    high                                    high                                    high                                        high                                         low                                         mid
  chr6            58856717    58857141    Herc3           maternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        low                                          mid                                         
  chr7            135831483   135832096   Inpp5f          maternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        mid                                          mid                                         
  chr15           72639967    72640553    Trappc9         maternal   yes                                   yes                                   yes                                    high   high                                    high                                    high                                        low                                          mid                                         

ATRX peaks were observed at 11 of 17 germline DMRs in the genome and showed mid-level enrichment at three more DMRs. ATRX also bound to five somatic DMRs in mouse ESCs. All regions were marked by DNA methylation and associated with high levels of H3K9me3 and H3.3. See also [Figure S3](#app3){ref-type="sec"}. Low, \<25^th^ percentile of genome CpGi; mid, \>25^th^ and \<75^th^ percentile of genome CpGi; high \>75^th^ percentile of genome CpGi.

Manually defined CpGi based on GC content.

Low-level ATRX enrichment missed in peak calls.

Categorized based on normalized read count relative to genome CpGi.
